Collections
-
-
Series |
2025 Neuropsychopharmacology Reviews: Neuroimaging in Psychiatry
This issue provides a snapshot of how recent advances in neuroimaging are on the cusp of transforming our understanding of the biological mechanisms underlying psychiatric disease states, providing an overview of the current state of the field, the challenges it faces, and future opportunities.
Image: Nicola Hawes, nicolahawes@gmail.com -
Series |
2024 Neuropsychopharmacology Reviews: Rapid and Novel Treatments in Psychiatry
Many in the field believe that psychiatry is in the early phases of a revolution in therapeutics. This issue of Neuropsychopharmacology Reviews presents an overview of the current state of rapid and novel treatments in psychiatry, with an eye on the future of this critical area.
Image: hxdyl/iStock/Getty -
Supplement |
Selected Abstracts from the American College of Neuropsychopharmacology (ACNP) 62nd Annual Meeting
Image: © Rawpixel Ltd./ iStock/ Thinkstock -
Supplement |
Selected Abstracts from the American College of Neuropsychopharmacology (ACNP) 61st Annual Meeting
Image: Image © Rawpixel Ltd./ iStock/ Thinkstock -
Collection |
Early Career Commentaries
A collection featuring the scientific voices, ideas, and perspectives of early career investigators.
Image: filadendron/Getty -
Series |
2022 Neuropsychopharmacology Reviews: Prefrontal Cortex
The prefrontal cortex (PFC) is essential for developing action plans, driven by the coordination of cognitive and emotional processes, that relies on both current goals and future plans.
Image: Haber Lab -
Supplement |
Selected Abstracts from the American College of Neuropsychopharmacology (ACNP) 60th Annual Meeting
Image: Image © Rawpixel Ltd./ iStock/ Thinkstock -
Special |
Highlighting Research on Health Disparities
A collection aimed at highlighting NPP articles and commentaries that address disparities related to gender, race, ethnicity, LGBTQ+ individuals, and early life adversity
Image: © LaylaBird/Getty. Used with permission. -
Series |
2021 Neuropsychopharmacology Reviews: Big Data in Psychiatry
It is now clear that unraveling how the brain creates behavior, and how this understanding can better inform new therapies and interventions, will require vast new approaches to tackling the complex problems in Neuroscience and Psychiatry. Fortunately, tremendous evolution in sample sizes, computing power, neuroimaging technologies, digital approaches to phenotyping, and computational modeling have rapidly brought in a new era of Big Data in Psychiatry. How we understand and utilize computational approaches to enormous data, from genomics to neuroimaging to phenotyping, may well determine our success as a field in the coming years. To address these issues, the 2021 Neuropsychopharmacology Reviews edition aims to cover a broad swath, from digital data collection, to neuroimaging across development, to multiomics across disorders, to computational approaches to Big Data in Psychiatry.
-
Supplement |
Selected Abstracts from the American College of Neuropsychopharmacology (ACNP) 59th Annual Meeting
Image: © Rawpixel Ltd./ iStock/ Thinkstock -
Collection |
BrainPod: NPP's Podcast
BrainPod is the podcast from the journal Neuropsychopharmacology, produced in association with Nature Publishing Group. Join us as we delve into the latest basic and clinical research that advance our understanding of the brain and behavior, featuring highlighted content from a top journal in fields of neuroscience, psychiatry, and pharmacology.
